Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EONS 2019 | The HPV vaccine for preventing cervical and oropharyngeal cancer

Daniel Kelly • 28 Sep 2019
EONS 2019
Cervical Cancer

Daniel Kelly, FRCN, RN, PhD, FRSA, Cardiff University, Cardiff, UK, stresses the importance of ensuring patient safety, with a focus on the human papillomavirus (HPV) vaccination to prevent cervical and oropharyngeal cancers, and how appropriate allocation of resources can help maintain patient safety. This interview took place at EONS 12 during the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Daniel Kelly

1:50
Prof. Kelly’s overview of the RECaN project
Daniel Kelly • 16 Apr 2019
2:14
Recognizing cancer nursing: a study across Europe
Daniel Kelly • 10 Nov 2017
0:57
Developing leadership skills in nursing
Daniel Kelly • 10 Nov 2017
1:07
The value of UKONS
Daniel Kelly • 10 Nov 2017

Related Videos

1:07
Immunotherapy in gynecological cancers
Sola Adeleke • 8 Dec 2023
2:30
Advancements in PARP inhibitors for cervical cancer
Clare Scott • 23 Oct 2023
1:54
Updates in gynecological cancers at ESMO 2023
Jalid Sehouli • 21 Oct 2023
3:48
AdvanTIG-202: tislelizumab +/- ociperlimab in recurrent/metastatic cervical cancer
Jung-Yun Lee • 20 Oct 2023
The content of VJOncology is intended for healthcare professionals